Dishman Carbogen Amcis Share Price Today | Stock Price & Dishman Carbogen Amcis Share Screener

Track the current stock price of Dishman Carbogen Amcis with an interactive chart. Analyse DCAL share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Dishman Carbogen Amcis stock quote in one place.

The quote of ₹151.50 sits between the 52-week low of ₹129.97 and the 52-week high of ₹297.60, and the latest session moved 0.76% from the previous close.

Screen Dishman Carbogen Amcis company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for DCAL shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE385W01011.

Classification

Identifiers and Leadership

Screen DCAL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹11,923, up from ₹9,999 in 2025.

Latest statistics put total assets at ₹11,923 and shareholder funds at ₹6,677, with a leverage ratio of 0.44.

Screen Dishman Carbogen Amcis income statement and profit fundamentals. Analyze DCAL quarterly results. Dishman Carbogen Amcis reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Mar, revenue was ₹868 and net profit was ₹22, equal to earnings per unit of ₹1.39, at an operating margin of 19%.

In that period expenses were ₹690, interest cost ₹43 and tax ₹24. The next period listed, 2026-Jun, shows revenue of ₹696 and net profit of ₹-58.

Screen DCAL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹492, and net cash flow was an inflow of ₹447.

Over the same period, investing activities used ₹245 and financing activities provided ₹201.

See Dishman Carbogen Amcis shareholding pattern with promoter, FII, and DII holdings. Check Dishman Carbogen Amcis promoter holding and ownership changes for DCAL on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 59.32%, foreign institutions 7.45%, domestic institutions 1.63% and the public 27.20%, spread across 49,009 shareholders.

The shareholder count was 49,009 in 2026-Mar, compared with 49,430 in 2026-Jun.

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Dishman Carbogen Amcis. Dishman Carbogen Amcis dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹0.00 per unit for 2026-March, a yield of 0.00%, compared with ₹0.00 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹0.00, ₹0.00 and ₹0.00 per unit.

See which indices include Dishman Carbogen Amcis stock. Check DCAL index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

The company is listed in 5 indices, including BSE 1000.

Among the benchmarks tracked are BSE 1000, BSE INDEX BSE HC, BSE INDEX SMLCAP, NIFTY MICROCAP250.

Get Dishman Carbogen Amcis corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Dishman Carbogen Amcis stock events that may affect DCAL share price, along with derivatives, futures and options activity and sector gainers.

13 corporate actions are listed, the most recent entry being Annual General Meeting dated September 30, 2026, with a record date of September 30, 2026.

It is followed by Quarterly Result Announcement dated August 14, 2026 and Extraordinary General Meeting dated June 19, 2026.

Screen DCAL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Screen DCAL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated October 4, 2026.

The next most recent announcements are dated October 1, 2026 and September 12, 2026.

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 5, 2026. This page covers 10 balance sheet periods, 15 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.